Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Experimental Hematology & Oncology|August 5, 2024
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatmentSilvia Vanni, Giacomo Miserocchi, Graziana Gallo, et al.
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
BJC Reports|November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trialMarta Ligero, Jorge Hernando, Eric Delgado, et al.
Cancers|July 9, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data AnalysisNicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
Neuro-Oncology|July 15, 2020
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenibAlessandra Santangelo, Marzia Rossato, Giuseppe Lombardi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult RhabdomyosarcomasAlessandro De Vita, Silvia Vanni, Valentina Fausti, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Tumor immune microenvironment-associated prognostic and mifamurtide-response gene signatures for localized osteosarcoma: a correlative study of the ISG/OS2 trialEmanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri, et al.
Experimental Hematology & Oncology|August 5, 2024
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatmentSilvia Vanni, Giacomo Miserocchi, Graziana Gallo, et al.
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
BJC Reports|November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trialMarta Ligero, Jorge Hernando, Eric Delgado, et al.
Cancers|July 9, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data AnalysisNicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
Neuro-Oncology|July 15, 2020
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenibAlessandra Santangelo, Marzia Rossato, Giuseppe Lombardi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult RhabdomyosarcomasAlessandro De Vita, Silvia Vanni, Valentina Fausti, et al.
Pageof 23